Screening of Variants in the Transcript Profile of Eutopic Endometrium from Infertile Women with Endometriosis during the Implantation Window

Abstract

Objective Abnormalities in the eutopic endometrium of women with endometriosis may be related to disease-associated infertility. Although previous RNA-sequencing analysis did not show differential expression in endometrial transcripts of endometriosis patients, other molecular alterations could impact protein synthesis and endometrial receptivity. Our aim was to screen for functional mutations in the transcripts of eutopic endometria of infertile women with endometriosis and controls during the implantation window.

Methods Data from RNA-Sequencing of endometrial biopsies collected during the implantation window from 17 patients (6 infertile women with endometriosis, 6 infertile controls, 5 fertile controls) were analyzed for variant discovery and identification of functional mutations. A targeted study of the alterations found was performed to understand the data into disease's context.

Results None of the variants identified was common to other samples within the same group, and no mutation was repeated among patients with endometriosis, infertile and fertile controls. In the endometriosis group, nine predicted deleterious mutations were identified, but only one was previously associated to a clinical condition with no endometrial impact. When crossing the mutated genes with the descriptors endometriosis and/or endometrium, the gene CMKLR1 was associated either with inflammatory response in endometriosis or with endometrial processes for pregnancy establishment.

Conclusion Despite no pattern of mutation having been found, we ponder the small sample size and the analysis on RNA-sequencing data. Considering the purpose of the study of screening and the importance of the CMKLR1 gene on endometrial modulation, it could be a candidate gene for powered further studies evaluating mutations in eutopic endometria from endometriosis patients.

Resumo

Objetivo Anormalidades no endométrio eutópico de mulheres com endometriose podem estar relacionadas à infertilidade associada à doença. Embora a análise prévia de sequenciamento de RNA não tenha evidenciado expressão diferencial em transcritos endometriais de pacientes com endometriose, outras alterações moleculares poderiam afetar a síntese de proteínas e a receptividade endometrial. Nosso objetivo foi rastrear mutações funcionais em transcritos de endométrios eutópicos de mulheres inférteis com endometriose e de controles durante a janela de implantação.

Métodos Os dados do sequenciamento de RNA de biópsias endometriais coletados durante a janela de implantação de 17 pacientes (6 mulheres inférteis com endometriose, 6 controles inférteis, 5 controles férteis) foram analisados para a descoberta de variantes e a identificação de mutações funcionais. Um estudo direcionado das alterações encontradas foi realizado para compreender os dados no contexto da doença.

Resultados Nenhuma das variantes identificadas foi comum a outras amostras dentro do mesmo grupo, assim como nenhuma mutação se repetiu entre pacientes com endometriose, controles inférteis e férteis. No grupo de endometriose, foram identificadas nove mutações deletérias preditas, mas apenas uma foi previamente associada a uma condição clínica sem impacto endometrial. Ao cruzar os genes mutados com os descritores endometriose e/ou endométrio, o gene CMKLR1 foi associado a resposta inflamatória na endometriose e a processos endometriais para estabelecimento da gravidez.

Conclusão Apesar de nenhum padrão de mutação ter sido encontrado, ponderamos o pequeno tamanho da amostra e a análise dos dados de sequenciamento de RNA. Considerando o objetivo do estudo de triagem e a importância do gene CMKLR1 na modulação endometrial, este poderia ser um gene candidato para estudos adicionais que avaliem mutações no endométrio eutópico de pacientes com endometriose.

Keywords

endometriosis - infertility - eutopic endometrium - RNA-sequencing - mutation

Palavras-chave

endometriose - infertilidade - endométrio eutópico - sequenciamento de RNA - mutação

Contributors

Da Broi M. G. was responsible for the study design, acquisition of data, data analysis, results interpretation, and manuscript writing. Plaça J. R. was responsible for the bioinformatics analysis and contributed to the data interpretation. Silva Jr, W. A. contributed to data interpretation and manuscript review. Ferriani R. A. contributed to revising critically the manuscript for important intellectual content. Navarro P. A. contributed to the study design, interpretation of data, critic review of the manuscript, and was the coordinator of the project. All authors have approved the final version and the submission of the manuscript.

Publication History

Received: 14 August 2020

Accepted: 12 February 2021

Article published online:
27 July 2021

• References

• 1 Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril 2012; 98 (03) 511-519 DOI: 10.1016/j.fertnstert.2012.06.029.
• 2 Gupta S, Agarwal A, Krajcir N, Alvarez JG. Role of oxidative stress in endometriosis. Reprod Biomed Online 2006; 13 (01) 126-134 DOI: 10.1016/s1472-6483(10)62026-3.
• 3 Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility: a committee opinion. Fertil Steril 2012; 98 (03) 591-598 DOI: 10.1016/j.fertnstert.2012.05.031.
• 4 Garrido N, Navarro J, Remohí J, Simón C, Pellicer A. Follicular hormonal environment and embryo quality in women with endometriosis. Hum Reprod Update 2000; 6 (01) 67-74 DOI: 10.1093/humupd/6.1.67.
• 5 Giudice LC, Kao LC. Endometriosis. Lancet 2004; 364 (9447): 1789-1799 DOI: 10.1016/S0140-6736(04)17403-5.
• 6 Gupta S, Goldberg JM, Aziz N, Goldberg E, Krajcir N, Agarwal A. Pathogenic mechanisms in endometriosis-associated infertility. Fertil Steril 2008; 90 (02) 247-257 DOI: 10.1016/j.fertnstert.2008.02.093.
• 7 Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility. Fertil Steril 2006; 86 (05, Suppl 1): S156-S160 DOI: 10.1016/j.fertnstert.2006.08.014.
• 8 Wei Q, St Clair JB, Fu T, Stratton P, Nieman LK. Reduced expression of biomarkers associated with the implantation window in women with endometriosis. Fertil Steril 2009; 91 (05) 1686-1691 DOI: 10.1016/j.fertnstert.2008.02.121.
• 9 Bulletti C, Coccia ME, Battistoni S, Borini A. Endometriosis and infertility. J Assist Reprod Genet 2010; 27 (08) 441-447 DOI: 10.1007/s10815-010-9436-1.
• 10 Giudice LC, Telles TL, Lobo S, Kao L. The molecular basis for implantation failure in endometriosis: on the road to discovery. Ann N Y Acad Sci 2002; 955: 252-264 , discussion 293–295, 396–406 DOI: 10.1111/j.1749-6632.2002.tb02786.x.
• 11 Minici F, Tiberi F, Tropea A, Orlando M, Gangale MF, Romani FR. et al. Endometriosis and human infertility: a new investigation into the role of eutopic endometrium. Hum Reprod 2008; 23 (03) 530-537 DOI: 10.1093/humrep/dem399.
• 12 Singh M, Chaudhry P, Asselin E. Bridging endometrial receptivity and implantation: network of hormones, cytokines, and growth factors. J Endocrinol 2011; 210 (01) 5-14 DOI: 10.1530/JOE-10-0461.
• 13 Kresowik JD, Devor EJ, Van Voorhis BJ, Leslie KK. MicroRNA-31 is significantly elevated in both human endometrium and serum during the window of implantation: a potential biomarker for optimum receptivity. Biol Reprod 2014; 91 (01) 17 DOI: 10.1095/biolreprod.113.116590.
• 14 Achache H, Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update 2006; 12 (06) 731-746 DOI: 10.1093/humupd/dml004.
• 15 Bourgain C, Devroey P. Histologic and functional aspects of the endometrium in the implantatory phase. Gynecol Obstet Invest 2007; 64 (03) 131-133 DOI: 10.1159/000101735.
• 16 Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 1999; 340 (23) 1796-1799 DOI: 10.1056/NEJM199906103402304.
• 17 Altmäe S, Esteban FJ, Stavreus-Evers A, Simón CS, Giudice L, Lessey BA. et al. Guidelines for the design, analysis and interpretation of ‘omics’ data: focus on human endometrium. Hum Reprod Update 2014; 20 (01) 12-28 DOI: 10.1093/humupd/dmt048.
• 18 Díaz-Gimeno P, Ruíz-Alonso M, Blesa D, Simón C. Transcriptomics of the human endometrium. Int J Dev Biol 2014; 58 (2-4): 127-137 DOI: 10.1387/ijdb.130340pd.
• 19 Hu S, Yao G, Wang Y, Xu H, Ji X, He Y. et al. Transcriptomic changes during the pre-receptive to receptive transition in human endometrium detected by RNA-Seq. J Clin Endocrinol Metab 2014; 99 (12) E2744-E2753 DOI: 10.1210/jc.2014-2155.
• 20 Paulson RJ. Hormonal induction of endometrial receptivity. Fertil Steril 2011; 96 (03) 530-535 DOI: 10.1016/j.fertnstert.2011.07.1097.
• 21 von Grothusen C, Lalitkumar S, Boggavarapu NR, Gemzell-Danielsson K, Lalitkumar PG. Recent advances in understanding endometrial receptivity: molecular basis and clinical applications. Am J Reprod Immunol 2014; 72 (02) 148-157 DOI: 10.1111/aji.12226.
• 22 Aghajanova L, Hamilton AE, Giudice LC. Uterine receptivity to human embryonic implantation: histology, biomarkers, and transcriptomics. Semin Cell Dev Biol 2008; 19 (02) 204-211 DOI: 10.1016/j.semcdb.2007.10.008.
• 23 Da Broi MG, Meola J, Plaça JR, Peronni KC, Rocha CV, Silva WA. et al. Is the profile of transcripts altered in the eutopic endometrium of infertile women with endometriosis during the implantation window?. Hum Reprod 2019; 34 (12) 2381-2390 DOI: 10.1093/humrep/dez225.
• 24 Katsonis P, Koire A, Wilson SJ, Hsu T-K, Lua RC, Wilkins AD. et al. Single nucleotide variations: biological impact and theoretical interpretation. Protein Sci 2014; 23 (12) 1650-1666 DOI: 10.1002/pro.2552.
• 25 Mueller SC, Backes C, Kalinina OV, Meder B, Stöckel D, Lenhof H-S. et al. BALL-SNP: combining genetic and structural information to identify candidate non-synonymous single nucleotide polymorphisms. Genome Med 2015; 7 (01) 65 DOI: 10.1186/s13073-015-0190-y.
• 26 Cirulli ET, Singh A, Shianna KV, Ge D, Smith JP, Maia JM. et al; Center for HIV/AIDS Vaccine Immunology (CHAVI). Screening the human exome: a comparison of whole genome and whole transcriptome sequencing. Genome Biol 2010; 11 (05) R57 DOI: 10.1186/gb-2010-11-5-r57.
• 27 Han L, Vickers KC, Samuels DC, Guo Y. Alternative applications for distinct RNA sequencing strategies. Brief Bioinform 2015; 16 (04) 629-639 DOI: 10.1093/bib/bbu032.
• 28 Sheng Q, Zhao S, Li CI, Shyr Y, Guo Y. Practicability of detecting somatic point mutation from RNA high throughput sequencing data. Genomics 2016; 107 (05) 163-169 DOI: 10.1016/j.ygeno.2016.03.006.
• 29 Quinn EM, Cormican P, Kenny EM, Hill M, Anney R, Gill M. et al. Development of strategies for SNP detection in RNA-seq data: application to lymphoblastoid cell lines and evaluation using 1000 Genomes data. PLoS One 2013; 8 (03) e58815 DOI: 10.1371/journal.pone.0058815.
• 30 Chepelev I, Wei G, Tang Q, Zhao K. Detection of single nucleotide variations in expressed exons of the human genome using RNA-Seq. Nucleic Acids Res 2009; 37 (16) e106 DOI: 10.1093/nar/gkp507.
• 31 Cánovas A, Rincon G, Islas-Trejo A, Wickramasinghe S, Medrano JF. SNP discovery in the bovine milk transcriptome using RNA-Seq technology. Mamm Genome 2010; 21 (11-12): 592-598 DOI: 10.1007/s00335-010-9297-z.
• 32 Peng Z, Cheng Y, Tan BC, Tian Z, Zhu Y, Zhang W. et al. Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome. Nat Biotechnol 2012; 30 (03) 253-260 DOI: 10.1038/nbt.2122.
• 33 Fraser IS, Critchley HO, Munro MG, Broder M. Writing Group for this Menstrual Agreement Process. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Fertil Steril 2007; 87 (03) 466-476 DOI: 10.1016/j.fertnstert.2007.01.023.
• 34 Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997; 67 (05) 817-821 DOI: 10.1016/s0015-0282(97)81391-x.
• 35 Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol 1975; 122 (02) 262-263 DOI: 10.1016/s0002-9378(16)33500-1.
• 36 Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 2013; 29 (01) 15-21 DOI: 10.1093/bioinformatics/bts635.
• 37 Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A. et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics 2013; 43 (1110): 1-33
• 38 Jin CH, Yi KW, Ha YR, Shin J-H, Park HT, Kim T. et al. Chemerin expression in the peritoneal fluid, serum, and ovarian endometrioma of women with endometriosis. Am J Reprod Immunol 2015; 74 (04) 379-386 DOI: 10.1111/aji.12405.
• 39 Stefl S, Nishi H, Petukh M, Panchenko AR, Alexov E. Molecular mechanisms of disease-causing missense mutations. J Mol Biol 2013; 425 (21) 3919-3936 DOI: 10.1016/j.jmb.2013.07.014.
• 40 Nakayama A, Matsuo H, Ohtahara A, Ogino K, Hakoda M, Hamada T. et al. Clinical practice guideline for renal hypouricemia (1st edition). Hum Cell 2019; 32 (02) 83-87
• 41 Dinour D, Gray NK, Campbell S, Shu X, Sawyer L, Richardson W. et al. Homozygous SLC2A9 mutations cause severe renal hypouricemia. J Am Soc Nephrol 2010; 21 (01) 64-72 DOI: 10.1681/ASN.2009040406.
• 42 Windpessl M, Ritelli M, Wallner M, Colombi M. A novel homozygous SLC2A9 mutation associated with renal-induced hypouricemia. Am J Nephrol 2016; 43 (04) 245-250 DOI: 10.1159/000445845.
• 43 Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G. et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007; 148 (10) 4687-4694 DOI: 10.1210/en.2007-0175.
• 44 Bozaoglu K, Segal D, Shields KA, Cummings N, Curran JE, Comuzzie AG. et al. Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J Clin Endocrinol Metab 2009; 94 (08) 3085-3088 DOI: 10.1210/jc.2008-1833.
• 45 Bozaoglu K, Curran JE, Stocker CJ, Zaibi MS, Segal D, Konstantopoulos N. et al. Chemerin, a novel adipokine in the regulation of angiogenesis. J Clin Endocrinol Metab 2010; 95 (05) 2476-2485 DOI: 10.1210/jc.2010-0042.
• 46 Bondue B, Wittamer V, Parmentier M. Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine Growth Factor Rev 2011; 22 (5-6): 331-338 DOI: 10.1016/j.cytogfr.2011.11.004.
• 47 Roh SG, Song SH, Choi KC, Katoh K, Wittamer V, Parmentier M. et al. Chemerin--a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun 2007; 362 (04) 1013-1018 DOI: 10.1016/j.bbrc.2007.08.104.
• 48 Weigert J, Neumeier M, Wanninger J, Filarski M, Bauer S, Wiest R. et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) 2010; 72 (03) 342-348 DOI: 10.1111/j.1365-2265.2009.03664.x.
• 49 Carlino C, Trotta E, Stabile H, Morrone S, Bulla R, Soriani A. et al. Chemerin regulates NK cell accumulation and endothelial cell morphogenesis in the decidua during early pregnancy. J Clin Endocrinol Metab 2012; 97 (10) 3603-3612 DOI: 10.1210/jc.2012-1102.
• 50 Maybin JA, Critchley HO, Jabbour HN. Inflammatory pathways in endometrial disorders. Mol Cell Endocrinol 2011; 335 (01) 42-51 DOI: 10.1016/j.mce.2010.08.006.
• 51 King AE, Critchley HO. Oestrogen and progesterone regulation of inflammatory processes in the human endometrium. J Steroid Biochem Mol Biol 2010; 120 (2-3): 116-126 DOI: 10.1016/j.jsbmb.2010.01.003.
• 52 Roberts M, Luo X, Chegini N. Differential regulation of interleukins IL-13 and IL-15 by ovarian steroids, TNF-alpha and TGF-beta in human endometrial epithelial and stromal cells. Mol Hum Reprod 2005; 11 (10) 751-760 DOI: 10.1093/molehr/gah233.